Call to Ban “Low Testosterone” Ads as “Disease-mongering”
An editorial in the Journal of the American Geriatrics Society has called for a ban on advertisements about testosterone replacement therapy, and the FDA has issued warnings about the practice.
We Need to Talk About Frankie
In this piece for The Cut, Dyan Neary details the story of Frankie Perry, a man whose life was forever altered by being prescribed an...
âClub Drug Ketamine Gains Traction As A Treatment For Depressionâ
NPR reports on how ketamine is being used off-label to treat depression.
Unsafe Use of Sleep Drug Zolpidem is Common
Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.
Reducing Overuse of Low-Value Treatments
Researchers provide an action-planning framework to engage providers in the reduction of low-value healthcare.
